{"id":729,"date":"2025-01-20T12:03:31","date_gmt":"2025-01-20T03:03:31","guid":{"rendered":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/?page_id=729"},"modified":"2025-01-22T11:43:39","modified_gmt":"2025-01-22T02:43:39","slug":"result","status":"publish","type":"page","link":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/dentistry\/result","title":{"rendered":"\u6b6f\u5b66\u7814\u7a76\u9662 \u696d\u7e3e\u4e00\u89a7"},"content":{"rendered":"<div class=\"area\">\n<ul>\n<li><a href=\"#001\">\u8ad6\u6587<\/a><\/li>\n<li><a href=\"#002\">\u5927\u578b\u5171\u540c\u7814\u7a76\u8cbb<\/a><\/li>\n<li><a href=\"#003\">\u7523\u696d\u5275\u51fa\u90e8\u9580\u306e\u5275\u8a2d<\/a><\/li>\n<li><a href=\"#004\">\u7279\u8a31<\/a><\/li>\n<li><a href=\"#005\">\u533b\u5e2b\u30fb\u4f01\u696d\u3068\u306e\u5171\u540c\u7814\u7a76<\/a><\/li>\n<li><a href=\"#006\">\u7af6\u4e89\u7684\u8cc7\u91d1<\/a><\/li>\n<\/ul>\n<\/div>\n<p><strong><span style=\"color: #3366ff;\">\uff15\u5e74\u9593\u5168\u4f53<\/span><\/strong><br \/>\n<strong><span style=\"color: #3366ff;\">\u539f\u8457\u8ad6\u6587\uff1a22\u5831\uff084+3+6+6+3\uff1d22\uff09Top10%\u88ab\u5f15\u7528\u8ad6\u6587\u306e\u5272\u540845.5\uff05<\/span><\/strong><br \/>\n<strong><span style=\"color: #3366ff;\">\u7dcf\u8aac\uff1a7\u5831\uff081+1+1+1+3\uff1d7\uff09Top10%\u88ab\u5f15\u7528\u8ad6\u6587\u306e\u5272\u540814.3\uff05<\/span><\/strong><br \/>\n<strong><span style=\"color: #3366ff;\">\u5408\u8a08\uff1a29\u5831\uff0822+7\uff1d29\uff09Top10%\u88ab\u5f15\u7528\u8ad6\u6587\u306e\u5272\u540838.0\uff05<\/span><\/strong><br \/>\n<strong><span style=\"color: #3366ff;\">\u3000Top10\uff05\uff1a11\u5831\uff1a\u9752<\/span><\/strong><br \/>\n<strong><span style=\"color: #ff0000;\">\u3000Top1%:\uff1a0\u5831\uff1a\u8d64<\/span><\/strong><br \/>\n<strong><span style=\"color: #339966;\">\u3000Top0.1%\uff1a0\u5831\uff1a\u7dd1<\/span><\/strong><\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h4 id=\"001\">\u8ad6\u6587<\/h4>\n<h6>2019\u5e74\u3000\u8ad6\u6587\uff08\u539f\u8457\uff0b\u7dcf\u8aac\uff1a\u82f1\u6587\uff09\u539f\u8457\uff1a4\u3001\u7dcf\u8aac\uff1a1\u3000Top10%\u88ab\u5f15\u7528\u8ad6\u6587\uff1a3 (60.0%)<\/h6>\n<ol>\n<li><span style=\"color: #3366ff;\">Annan DA, Maishi N, Soga T, Dawood RIH, Li C, Kikuchi H, Hojo T, Morimoto M, Kitamura T, Alam MT, Minowa K, Shinohara N, Nam JM, Hida Y and *<u>Hida K<\/u>\uff1aCarbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment, <strong><em>Cell Commun. Signal.,<\/em><\/strong> 17, 169, 2019 doi: 10.1186\/s12964-019-0478-4<\/span><\/li>\n<li>Maishi N.\u00a7, Kikuchi. H\u00a7, Sato M, Nagao-Kitamoto H, Annan DA, Baba S, Hojo T, Yanagiya M, Ohba Y, Ishii G, Masutomi K, Shinohara N, Hida Y and *<u>Hida K<\/u>: Development of immortalized human tumor endothelial cells from renal cancer, <strong><em> J. Mol. Sci.<\/em><\/strong>, <strong>equally contributed, <\/strong>20, 4595, 2019 doi: 10.3390\/ijms20184595<\/li>\n<li>Sakurai Y, Kato A, Hida Y, Hamada J, Maishi N, <u>Hida K<\/u>. Harashima H: Synergistic enhancement of cellular uptake with CD44-expressing malignant pleural mesothelioma by combining cationic liposome and hyaluronic acid-lipid conjugate, <strong><em> Pharm. Sci.<\/em><\/strong>, 108, 3218-3224, 2019 doi:10.1016\/j.xphs.2019.06.012<\/li>\n<li><span style=\"color: #3366ff;\">Akatsu Y, Takahashi N, Yoshimatsu Y, Kimuro S, Muramatsu T, Katsura A, Maishi N, Suzuki H, Inazawa J, Hida K, Miyazono K, and Watabe T: Fibroblast growth factor signals regulate transforming growth factor-\u03b2-induced endothelial-to-myofibroblast transition of tumor endothelial cells via Elk1, <strong><em> Oncol.,<\/em><\/strong> 13(8), 1706-1724, 2019 doi: 10.1002\/1878-0261.12504<\/span><\/li>\n<li><span style=\"color: #3366ff;\">Maishi N, Annan DA, Kikuchi H, Hida Y and Hida K*: Tumor endothelial heterogeneity in cancer progression, <strong><em>Cancers<\/em><\/strong>, 11(10), 1511, 2019 doi: 10.3390\/cancers11101511.<\/span><\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>2020\u5e74\u3000\u8ad6\u6587\uff08\u539f\u8457\uff0b\u7dcf\u8aac\uff1a\u82f1\u6587\uff09\u539f\u8457\uff1a3\u3001\u7dcf\u8aac\uff1a1\u3000Top10%\u88ab\u5f15\u7528\u8ad6\u6587\uff1a1 (25.0%)<\/h6>\n<ol>\n<li>Kikuchi H, Maishi N, Annan DA, Alam MT, Dawood RIH, Sato M, Morimoto M, Takeda R, Ishizuka K, Matsumoto R, Akino T, Tsuchiya K, Abe T, Osawa T, Miyajima N, Maruyama S, Harabayashi T, Azuma M, Yamashiro K, Ameda K, Kashiwagi A, Matsuno Y, Hida Y, Shinohara N and *Hida K: Chemotherapy-induced IL-8 upregulates MDR1\/ABCB1 in tumor blood vessels and results in unfavorable outcome, <strong><em>Cancer Res<\/em><\/strong>., 80(14), 2996-3008, 2020 doi:10.1158\/0008-5472.CAN-19-3791<\/li>\n<li><span style=\"color: #3366ff;\">Yoshimatsu Y, Wakabayashi I, Kimuro, S, Takahashi N, Takahashi K, Kobayashi, M, Maishi N, Inoue K, Hida K, Miyazono K, Watabe T: TNF-\u03b1 enhances TGF-\u03b2-induced endothelial-to-mesenchymal transition via TGF-\u03b2 signal augmentation, <strong><em>Cancer Sci.<\/em><\/strong>, 111(7), 2385-2399, 2020 doi: 10.1111\/cas.14455.<\/span><\/li>\n<li>Annan DA, Kikuchi H, Maishi N, Hida Y and <u>Hida K<\/u>*: Tumor Endothelial Cell\uff0dA Biological Tool for Translational Cancer Research, <strong><em> J. Mol. Sci<\/em><\/strong>., 21, 3238, 2020 doi: 10.3390\/ijms21093238<\/li>\n<li>Toshihiro Kushibiki, Toru Nakamura, Masumi Tsuda, Takahiro Tsuchikawa, Koji Hontani, Kazuho Inoko, Mizuna Takahashi, Toshimichi Asano, Keisuke Okamura, Soichi Murakami, Yo Kurashima, Yuma Ebihara, Takehiro Noji, Yoshitsugu Nakanishi, Kimitaka Tanaka, Nako Maishi, Katsunori Sasaki, Woong-Ryeon Park, Toshiaki Shichinohe, Kyoko Hida, Shinya Tanaka, Satoshi Hirano: Role of Dimerized C16orf74 in Aggressive Pancreatic Cancer: A Novel Therapeutic Target, <strong><em>Mol Cancer Ther.<\/em><\/strong> 19(1):187-198, 2020 doi: 10.1158\/1535-7163.MCT-19-0491<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>2021\u5e74\u3000\u8ad6\u6587\uff08\u539f\u8457\uff0b\u7dcf\u8aac\uff1a\u82f1\u6587\uff09\u539f\u8457\uff1a6\u3001\u7dcf\u8aac\uff1a1\u3000Top10%\u88ab\u5f15\u7528\u8ad6\u6587\uff1a2 (28.6%)<\/h6>\n<ol>\n<li>George N.Tzanakakis, Eirini-Maria Giatagana, Aikaterini Berdiaki, Ioanna Spyridaki, <u>Hida K<\/u>, Monica Neagu, Aristidis M. Tsatsakis, and Dragana Nikitovic *: The role of IGF\/IGF-IR-signaling and extracellular matrix effectors in sarcoma pathogenesis, <strong><em>Cancers<\/em><\/strong>, 13(10), 2478, 2021 doi: 10.3390\/cancers13102478<\/li>\n<li>Nishiyama K, Takahashi K, Fukuyama M, Kasuya M, Imai A, Usukura T, Maishi N, Maeki M, Ishida A, Tani H, <u>Hida K<\/u>, Shigemura K, Hibara A, Tokeshi M: Facile and rapid detection of SARS-CoV-2 antibody based on a noncompetitive fluorescence polarization immunoassay in human serum samples, <strong><em> Bioelectron.<\/em><\/strong>, (2021) 190:113414. doi: 10.1016\/j.bios.2021.113414.<\/li>\n<li>Torii C, Maishi N, Kawamoto T, Morimoto M, Akiyama K, Yoshioka Y, Minami T, Tsumita T, Alam MT, Ochiya T, Hida Y, *<u>Hida K<\/u>: miRNA-1246 in extracellular vesicles secreted from metastatic tumor induces drug resistance in tumor endothelial cells, <strong><em>Sci Rep,<\/em><\/strong> 2021 11:13502 2021 doi: 10.1038\/s41598-021-92879-5.<\/li>\n<li><span style=\"color: #3366ff;\">Li C, Maishi N, Annan DA, Young MF, Morimoto H, Morimoto M, Nam JM, Hida Y, *<u>Hida K<\/u>: Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy, <strong><em>Breast Cancer Res.<\/em><\/strong>, 23:51 2021 org\/10.1186\/s13058-021-01423-w<\/span><\/li>\n<li>Yanagiya M, Dawood RIH, Maishi N, Hida Y, Torii C, Annan DA, Kikuchi H, Yanagawa Matsuda A, Kitamura T, Tei K, Shindoh M, Tanaka S, Kitagawa Y, *<u>Hida K<\/u>: Correlation between endothelial chemokine receptor 7CXCR7 expression and clinicopathological factors in oral squamous cell carcinoma, <strong><em> Int, <\/em><\/strong>71:383\u2013391. 2021 doi: 10.1111\/pin.13094<\/li>\n<li>Morimoto H, Hida Y, Maishi N, Nishihara H, Hatanaka Y, Li C, Matsuno Y, Nakamura T, Hirano S, *<u>Hida K<\/u>: Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer, <strong><em> Cancer<\/em><\/strong>, 12(9), 1347-1357, 2021 doi:10.1111\/1759-7714.13907<\/li>\n<li><span style=\"color: #3366ff;\">Hiradate R, Khalil IA, Matsuda A, Sasaki M, <u>Hida K<\/u>, Harashima H: A novel dual-targeted rosiglitazone-loaded nanoparticle for the prevention of diet-induced obesity via the browning of white adipose tissue, <strong><em> Control. Release<\/em><\/strong>, 329(10), 665-675, 2021 doi: 10.1016\/j.jconrel.2020.10.002<\/span><\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>2022\u5e74\u3000\u8ad6\u6587\uff08\u539f\u8457\uff0b\u7dcf\u8aac\uff1a\u82f1\u6587\uff09\u539f\u8457\uff1a6\u3001\u7dcf\u8aac\uff1a1\u3000Top10%\u88ab\u5f15\u7528\u8ad6\u6587\uff1a3 (42.9%)<\/h6>\n<ol>\n<li>Lucas Treps, Ann Ager and Hida K: Editorial: Tumor Vessels as Directors of the Tumor Microenvironment: New Findings, Current Challenges &amp; Perspectives. <strong><em> Cell Dev. Biol.<\/em><\/strong> Volume 10, Article 885670, March 2022. (IF=6.684) doi: 10.3389\/fcell.2022.885670<\/li>\n<li>Nurina Febriyanti Ayuningtyas, Chanbora Chea, Toshinori Ando, Karina Erda Saninggar, Keiji Tanimoto, Toshihiro Inubushi, Nako Maishi, Kyoko Hida, Masanobu Shindo, Mutsumi Miyauchi *, Takashi Takata *: Bovine lactoferrin suppresses tumor angiogenesis through NF-\u03baB pathway inhibition by binding to TRAF6. <strong><em>Pharmaceutics<\/em><\/strong>, 15(1): 165, 2022. (IF=6.239) doi: 10.3390\/pharmaceutics15010165<\/li>\n<li>Furumido J, Maishi N, Yanagawa-Matsuda A, Kikuchi H, Matsumoto R, Osawa, T, Abe T, ; Matsuno Y, Shinohara N, Hida Y, Hida K*: Stroma Biglycan Expression can be a Prognostic Factor in Prostate Cancers. <strong><em>Int J Urol<\/em><\/strong>, 2022. (IF=3.011) doi:10.1111\/iju.15080<\/li>\n<li><span style=\"color: #3366ff;\">Takeda R, Sawa H, Sasaki M, Orba Y, Maishi N, Tsumita T, Ushijima N, Hida Y, Sano H, Kitagawa Y &amp; Hida K*: Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2. <strong><em>Sci Rep<\/em><\/strong>, 12:14050, 2022. (IF=5.516) doi: 10.1038\/s41598-022-18367-6<\/span><\/li>\n<li><span style=\"color: #3366ff;\">Yu L, Maishi N, Akahori E, Hasebe A, Takeda R, Yanagawa-Matsuda A, Hida Y, Nam Jin-Min, Onodera Y, Kitagawa Y, Hida K*: The oral bacterium Streptococcus mutans promotes tumor metastasis by inducing vascular inflammation. <strong><em>Cancer Sci<\/em><\/strong>, 113:3980\u20133994, 2022. (IF=6.622) doi: 10.1111\/cas.15538<\/span><\/li>\n<li><span style=\"color: #3366ff;\">Tsumita T, Maishi N, Annan DA, Alam MT, Matsuda A, Onodera Y, Nam JM, Hida Y, Hida K: The oxidized-LDL\/LOX-1 axis in tumor endothelial cells enhances metastasis by recruiting neutrophils and cancer cells. <strong><em> J. Cancer<\/em><\/strong>, 151(6), 944-956, 2022 (selected as a cover) (IF=7.968) doi: org\/10.1002\/ijc.34134<\/span><\/li>\n<li>Maishi N, Sakurai Y, Hatakeyama H, Umeyama Y, Nakamura T, Endo R, Alam MT, Li C, Annan DA, Kikuchi H, Morimoto H, Morimoto M, Akiyama K, Ohga N, Hida Y, Harashima H, *Hida K: Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system, <strong><em>Cancer Sci<\/em><\/strong>., 113(5),1855-1867, 2022. (IF=6.622) doi: 10.1111\/cas.15323<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6>2023\u5e74\u3000\u8ad6\u6587\uff08\u539f\u8457\uff0b\u7dcf\u8aac\uff1a\u82f1\u6587\uff09\u539f\u8457\uff1a3\u3001\u7dcf\u8aac\uff1a3\u3000Top10%\u88ab\u5f15\u7528\u8ad6\u6587\uff1a2 (33.3%)<\/h6>\n<ol>\n<li>Tsumita T \u00a7\uff0cTakeda R \u00a7, Maishi N, Hida Y, Sasaki M, Orba Y, Sato A, Toba S, Ito W, Teshirogi T, Sakurai Y, Iba T, Naito H, Ando H, Watanabe H, Mizuno A, Nakanishi T, Matsuda A, Zixiao<\/li>\n<li>R, Lee JW\uff0cIimura T, Sawa H*,\u00a0 Hida K*: Viral uptake and pathophysiology of the lung endothelial cells in age-associated severe SARS-CoV-2 infection models, <strong><em>Aging Cell<\/em><\/strong>, 2023, e14050, doi: 10.1111\/acel.14050<\/li>\n<li>Yu L, Maishi N, Matsuda A, Hida K*: The functional network of biglycan: a new frontier in tumor progression. <strong><em>Proteoglycan Res<\/em><\/strong>, 2023. (IF=0) doi: 10.1002\/pgr2.11<\/li>\n<li>Haruhisa Watanabe, Nako Maishi, Marie Hoshi-Numahata, Mai Nishiura, Atsuko Nakanishi-Kimura, Kyoko Hida and Tadahiro Iimura*: Skeletal-Vascular Interactions in Bone Development, Homeostasis, and Pathological Destruction. <strong><em> J. Mol. Sci<\/em><\/strong>. 24, 10192, 2023. (IF= 6.132) doi:10.3390\/ijms241310912<\/li>\n<li>Hida K*, Maishi N, Matsuda A, Yu L: Beyond starving cancer, antiangiogenic therapy. <strong><em>J Med Ultrasonic<\/em><\/strong>, 2023. (IF= 1.457) doi:10.1007\/s10396-023-01310-1<\/li>\n<li><span style=\"color: #3366ff;\">Morimoto M, Maishi N, Tsumita T, Alam MT, Kikuchi H, Hida Y, Yoshioka Y, Ochiya T, Annan DA, Takeda R, Kitagawa Y, Hida K: miR-1246 in tumor extracellular vesicles promotes metastasis via increased tumor cell adhesion and endothelial cell barrier destruction. <strong><em> Oncol<\/em><\/strong>, 13, 2023. (IF=6.122) doi:10.3389\/fonc.2023.973871\/<\/span><\/li>\n<li><span style=\"color: #3366ff;\">Sato M, Maishi N, Hida Y, Yanagawa-Matsuda A, Alam MT, Sakakibara-Konishi J, Nam JM, Onodera Y, Konno S, Hida K: Angiogenic inhibitor pre-administration improves the therapeutic effects of immunotherapy. <strong><em>Cancer Med<\/em><\/strong>, 12(8), 9760-9773, 2023. (IF=4.609) doi: 10.1002\/cam4.5696<\/span><\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h4 id=\"002\">\u5927\u578b\u5171\u540c\u7814\u7a76\u8cbb\uff08\u5e74\u9593500\u4e07\u5186\u4ee5\u4e0a\uff09<\/h4>\n<p>\u306a\u3057<\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h4 id=\"003\">\u7523\u696d\u5275\u51fa\u90e8\u9580\u306e\u5275\u8a2d<\/h4>\n<p>\u306a\u3057<\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h4 id=\"004\">\u7279\u8a31<\/h4>\n<p>\u306a\u3057<\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h4 id=\"005\">\u533b\u5e2b\u30fb\u4f01\u696d\u3068\u306e\u5171\u540c\u7814\u7a76<\/h4>\n<p>\u975e\u516c\u958b<\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h4 id=\"006\">\u7af6\u4e89\u7684\u8cc7\u91d1<\/h4>\n<h5>\u00a0<\/h5>\n<h5>\u2160. \u79d1\u7814\u8cbb\u30fb\u8ca1\u56e3<\/h5>\n<p><span style=\"color: #ff0000;\">5\u5e74\u9593\u5408\u8a08\u3000\u79d1\u7814\u8cbb\uff1a6,345\u4e07\u5186\u3000\u8ca1\u56e3\uff1a930\u4e07\u5186\u3000\u7dcf\u984d\uff1a7,275\u4e07\u5186<\/span><\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6><span style=\"color: #3366ff;\">2019\u5e74\u3000\u79d1\u7814\u8cbb\uff1a720\u4e07\u5186\u3000\u8ca1\u56e3\uff1a230\u4e07\u5186<\/span><\/h6>\n<ol>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08B\uff09 2019 <u>\u6a0b\u7530\u4eac\u5b50<\/u><u>\uff08\u4ee3\u8868\uff09<\/u> 450\u4e07\u5186, \uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a18H02996\uff09\u300c\u53e3\u8154\u304c\u3093\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u306b\u3088\u308b\u304c\u3093\u306e\u8ee2\u79fb\u4fc3\u9032\u6a5f\u69cb\u306e\u89e3\u660e\u3068\u8ee2\u79fb\u5236\u5fa1\u3078\u306e\u5fdc\u7528\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08C\uff092019 \u9593\u77f3\u5948\u6e56\uff08\u4ee3\u8868\uff09110\u4e07\u5186\uff0c\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a18K09715\uff09\u300c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306b\u3088\u308b\u8ee2\u79fb\u4fc3\u9032\u6a5f\u69cb\u89e3\u660e\u306e\u305f\u3081\u306e\u57fa\u76e4\u7684\u7814\u7a76\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08C\uff092019 \u5927\u5ee3\u6d0b\u4e00\uff08\u4ee3\u8868\uff0930\u4e07\u5186, \u6a0b\u7530\u4eac\u5b50, \u5317\u6751\u54f2\u4e5f(\u5206\u62c5) \uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a19K10350\uff09\u300c\u53e3\u8154\u304c\u3093\u306e\u8ee2\u79fb\u306b\u95a2\u308f\u308b\u53e3\u8154\u5e38\u5728\u83cc\u306e\u89e3\u6790\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08C\uff092019 \u4f50\u91ce\u82f1\u5f66\uff08\u4ee3\u8868\uff0930\u4e07\u5186, \u6a0b\u7530\u4eac\u5b50(\u5206\u62c5)\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a19K10123\uff09\u300c\u6b6f\u9ac4\u306e\u6cbb\u7652\u4fc3\u9032\u3068\u786c\u7d44\u7e54\u63a5\u7740\u6027\u3092\u4f75\u305b\u6301\u3064\u9769\u65b0\u7684\u76f4\u63a5\u8986\u9ac4\u6750\u306e\u63a2\u7d22\u7814\u7a76\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08B\uff092019 \u6a0b\u7530\u6cf0\u6d69\uff08\u4ee3\u8868\uff09100\u4e07\u5186, \u6a0b\u7530\u4eac\u5b50, \u9593\u77f3\u5948\u6e56(\u5206\u62c5)\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a18H02891\uff09\u300c\u6b63\u5e38\u8840\u7ba1\u306b\u4f5c\u7528\u3057\u306a\u3044\u60aa\u6027\u816b\u760d\u7279\u7570\u7684\u8840\u7ba1\u963b\u5bb3\u5264\u306e\u30cf\u30a4\u30b9\u30eb\u30fc\u30d7\u30c3\u30c8\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u300d<\/li>\n<li>\u30b5\u30ce\u30d5\u30a3\u682a\u5f0f\u4f1a\u793e\u3000\u7814\u7a76\u30fb\u6559\u80b2\u652f\u63f4\u30002019\u5e74\u5ea6\uff0c<u>\u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff09<\/u>200\u4e07\u5186\u300c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u6a19\u7684\u5316\u306b\u3088\u308b\u85ac\u5264\u8010\u6027\u514b\u670d\u6226\u7565\u306e\u69cb\u7bc9\u300d<\/li>\n<\/ol>\n<p>\u3000\u3000\u7814\u7a76\u6210\u679c\uff1a\u8840\u7ba1\u5185\u76ae\u306e\u85ac\u5264\u8010\u6027\u306b\u95a2\u308f\u308bmiR\u3092\u540c\u5b9a\u3057\u305f\u3002<\/p>\n<ol start=\"7\">\n<li>\u4e2d\u5916\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u3000\u7814\u7a76\u6d3b\u52d5\u652f\u63f4\u30002019\u5e74\u5ea6\uff0c<u>\u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff09<\/u>30\u4e07\u5186\u300c\u304c\u3093\u514d\u75ab\u306b\u304a\u3051\u308b\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u5f79\u5272\u300d<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6><span style=\"color: #3366ff;\">2020\u5e74\u3000\u79d1\u7814\u8cbb\uff1a405\u4e07\u5186\u3000\u8ca1\u56e3\uff1a240\u4e07\u5186<\/span><\/h6>\n<ol>\n<li>\u4e0a\u539f\u8a18\u5ff5\u751f\u547d\u79d1\u5b66\u8ca1\u56e3\u30002020\u5e74\u5ea6\u7814\u7a76\u5968\u52b1\u91d1\uff08\u5065\u5eb7\u79d1\u5b66\u30fb\u533b\u5b66\u30fb\u85ac\u5b66\uff09\u9593\u77f3\u5948\u6e56\uff08\u4ee3\u8868\uff09200\u4e07\u5186\u300c\u816b\u760d\u2f8e\u7ba1\u306e\u5f79\u5272\u89e3\u660e\u306b\u3088\u308b\u65b0\u898f\u8a3a\u65ad\u30fb\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u300d<\/li>\n<li>\u4f0a\u85e4\u533b\u85ac\u5b66\u8853\u4ea4\u6d41\u8ca1\u56e3\u3000\u7b2c26\u56de\uff082020\u5e74\u5ea6\uff09\u6d77\u5916\u5b66\u4f1a\u7b49\u51fa\u5e2d\u7814\u7a76\u4ea4\u6d41\u52a9\u6210\u3000\u7a4d\u7530\u5353\u4e5f\uff08\u4ee3\u8868\uff09 10\u4e07\u5186\u300c\u816b\u760d\u8840\u7ba1\u306b\u304a\u3051\u308b\u9178\u5316LDL\u53d7\u5bb9\u4f53\u306e\u5f79\u5272\u300d<\/li>\n<li>\u4e2d\u5916\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u3000\u7814\u7a76\u6d3b\u52d5\u652f\u63f4\u30002020\u5e74\u5ea6\uff0c\u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff0930\u4e07\u5186\u300c\u5149\u514d\u75ab\u7642\u6cd5\u306b\u304a\u3051\u308b\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u7642\u6cd5\u306e\u4f75\u7528\u52b9\u679c\u306e\u691c\u8a3c\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08B\uff09 2020 <u>\u6a0b\u7530\u4eac\u5b50<\/u><u>\uff08\u4ee3\u8868\uff09<\/u> 75\u4e07\u5186, \uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a18H02996\uff09\u300c\u53e3\u8154\u304c\u3093\u30a8\u30af\u30bd\u30bd\u30fc\u30e0\u306b\u3088\u308b\u304c\u3093\u306e\u8ee2\u79fb\u4fc3\u9032\u6a5f\u69cb\u306e\u89e3\u660e\u3068\u8ee2\u79fb\u5236\u5fa1\u3078\u306e\u5fdc\u7528\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76(C) 2020\u3000\u4f50\u85e4\u5343\u6674\uff08\u4ee3\u8868\uff0930\u4e07\u5186\uff0c\u9593\u77f3\u5948\u6e56, Annan DA\uff08\u5206\u62c5\uff09\u300c\u304c\u3093\u5e79\u7d30\u80de\u8840\u7ba1\u30cb\u30c3\u30c1\u3092\u6a19\u7684\u3068\u3057\u305f\u53e3\u8154\u304c\u3093\u6cbb\u7642\u3078\u306e\u5fdc\u7528\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76(C) 2020 \u677e\u7530\u3000\u5f69\uff08\u4ee3\u8868\uff09110\u4e07\u5186\u300c\u816b\u760d\u8840\u7ba1\u7531\u6765\u56e0\u5b50\u3092\u6a19\u7684\u3068\u3057\u305f\u816b\u760d\u6eb6\u89e3\u30a6\u30a4\u30eb\u30b9\u306e\u958b\u767a\u300d, \u6a0b\u7530\u4eac\u5b50, \u6771\u91ce\u53f2\u88d5, \u9593\u77f3\u5948\u6e56\uff08\u5206\u62c5\uff09<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08C\uff092020 \u5927\u5ee3\u6d0b\u4e00\uff08\u4ee3\u8868\uff0930\u4e07\u5186, \u6a0b\u7530\u4eac\u5b50, \u5317\u6751\u54f2\u4e5f(\u5206\u62c5) \uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a19K10350\uff09\u300c\u53e3\u8154\u304c\u3093\u306e\u8ee2\u79fb\u306b\u95a2\u308f\u308b\u53e3\u8154\u5e38\u5728\u83cc\u306e\u89e3\u6790\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08C\uff092020 \u4f50\u91ce\u82f1\u5f66\uff08\u4ee3\u8868\uff0930\u4e07\u5186, \u6a0b\u7530\u4eac\u5b50(\u5206\u62c5)\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a19K10123\uff09\u300c\u6b6f\u9ac4\u306e\u6cbb\u7652\u4fc3\u9032\u3068\u786c\u7d44\u7e54\u63a5\u7740\u6027\u3092\u4f75\u305b\u6301\u3064\u9769\u65b0\u7684\u76f4\u63a5\u8986\u9ac4\u6750\u306e\u63a2\u7d22\u7814\u7a76\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08B\uff092020 \u6a0b\u7530\u6cf0\u6d69\uff08\u4ee3\u8868\uff09100\u4e07\u5186, \u6a0b\u7530\u4eac\u5b50, \u9593\u77f3\u5948\u6e56(\u5206\u62c5)\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a18H02891\uff09\u300c\u6b63\u5e38\u8840\u7ba1\u306b\u4f5c\u7528\u3057\u306a\u3044\u60aa\u6027\u816b\u760d\u7279\u7570\u7684\u8840\u7ba1\u963b\u5bb3\u5264\u306e\u30cf\u30a4\u30b9\u30eb\u30fc\u30d7\u30c3\u30c8\u30b9\u30af\u30ea\u30fc\u30cb\u30f3\u30b0\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08C\uff092020 \u9593\u77f3\u5948\u6e56\uff08\u4ee3\u8868\uff0930\u4e07\u5186\uff0c\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a18K09715\uff09\u300c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u306b\u3088\u308b\u8ee2\u79fb\u4fc3\u9032\u6a5f\u69cb\u89e3\u660e\u306e\u305f\u3081\u306e\u57fa\u76e4\u7684\u7814\u7a76\u300d<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6><span style=\"color: #3366ff;\">2021\u5e74\u3000\u79d1\u7814\u8cbb\uff1a2,180\u4e07\u5186\u3000\u8ca1\u56e3\uff1a130\u4e07\u5186<\/span><\/h6>\n<ol>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08A\uff092021\u3000\u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff091,500\u4e07\u5186\u3000\u9593\u77f3\u5948\u6e56, \u677e\u7530\u3000\u5f69\uff08\u5206\u62c5\uff09\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a21H04840\uff09\u300c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u56e0\u5b50\u6a19\u7684\u306b\u3088\u308b\u304c\u3093\u514d\u75ab\u306e\u6d3b\u6027\u5316\u3068\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u958b\u767a\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08B\uff092021\u3000\u6a0b\u7530\u6cf0\u6d69\uff08\u4ee3\u8868\uff09100\u4e07\u5186 \u6a0b\u7530\u4eac\u5b50\uff0c\u9593\u77f3\u5948\u6e56\uff08\u5206\u62c5\uff09\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a21H03019\uff09\u300c\u816b\u760d\u7279\u7570\u7684\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264\u3068\u30c9\u30e9\u30c3\u30b0\u30ea\u30dd\u30b8\u30b7\u30e7\u30cb\u30f3\u30b0\u306b\u3088\u308b\u65b0\u898f\u80ba\u764c\u6cbb\u7642\u306e\u958b\u767a\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08C\uff092021\u3000\u677e\u7530\u3000\u5f69\uff08\u4ee3\u8868\uff0990\u4e07\u5186\u3000\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a20K09900\uff09\u300c\u816b\u760d\u8840\u7ba1\u7531\u6765\u56e0\u5b50\u3092\u6a19\u7684\u3068\u3057\u305f\u816b\u760d\u6eb6\u89e3\u30a6\u30a4\u30eb\u30b9\u306e\u958b\u767a\u300d<\/li>\n<li>\u65e5\u672c\u5b66\u8853\u632f\u8208\u4f1a\u7279\u5225\u7814\u7a76\u54e1\u5968\u52b1\u8cbb\uff08DC2\uff092021 \u7a4d\u7530\u5353\u4e5f\u300050\u4e07\u5186\u300c\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306b\u6ce8\u76ee\u3057\u305f\u300c\u304c\u3093\u300d\u3068\u300c\u5faa\u74b0\u5668\u75be\u60a3\u300d\u306e\u5171\u901a\u5206\u5b50\u75c5\u614b\u57fa\u76e4\u306e\u63a2\u7d22\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76(C) 2021\u3000\u9593\u77f3\u5948\u6e56\uff08\u4ee3\u8868\uff09140\u4e07\u5186\u300c\u304c\u3093\u3068\u816b\u760d\u8840\u7ba1\u306e\u76f8\u4e92\u4f5c\u7528\u306b\u3088\u308b\u65b0\u305f\u306a\u8ee2\u79fb\u4fc3\u9032\u6a5f\u69cb\u306e\u89e3\u660e\u3068\u305d\u306e\u5236\u5fa1\u300d\u6a0b\u7530\u4eac\u5b50, \u677e\u7530\u3000\u5f69\uff08\u5206\u62c5\u8005\uff09\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a21K10107\uff09<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76(C) 2021\u3000\u6885\u5c71\u60a0\u4f0a\uff08\u4ee3\u8868\uff09210\u4e07\u5186\u300c\u816b\u760d\u8840\u7ba1\u30c8\u30e9\u30f3\u30b9\u30dd\u30fc\u30bf\u30fc\u3092\u6a19\u7684\u3068\u3057\u305f\u85ac\u5264\u8010\u6027\u53e3\u8154\u304c\u3093\u306e\u5236\u5fa1\u300d\u6a0b\u7530\u4eac\u5b50, \u9593\u77f3\u5948\u6e56, \u677e\u7530\u3000\u5f69\uff08\u5206\u62c5\u8005\uff09\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a21K10036\uff09<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08C\uff092021 \u5927\u5ee3\u6d0b\u4e00\uff08\u4ee3\u8868\uff0930\u4e07\u5186, \u6a0b\u7530\u4eac\u5b50, \u5317\u6751\u54f2\u4e5f(\u5206\u62c5) \uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a19K10350\uff09\u300c\u53e3\u8154\u304c\u3093\u306e\u8ee2\u79fb\u306b\u95a2\u308f\u308b\u53e3\u8154\u5e38\u5728\u83cc\u306e\u89e3\u6790\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08C\uff092021 \u4f50\u91ce\u82f1\u5f66\uff08\u4ee3\u8868\uff0930\u4e07\u5186, \u6a0b\u7530\u4eac\u5b50(\u5206\u62c5)\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a19K10123\uff09\u300c\u6b6f\u9ac4\u306e\u6cbb\u7652\u4fc3\u9032\u3068\u786c\u7d44\u7e54\u63a5\u7740\u6027\u3092\u4f75\u305b\u6301\u3064\u9769\u65b0\u7684\u76f4\u63a5\u8986\u9ac4\u6750\u306e\u63a2\u7d22\u7814\u7a76\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76(C) 2021\u3000\u4f50\u85e4\u5343\u6674\uff08\u4ee3\u8868\uff0930\u4e07\u5186\uff0c\u9593\u77f3\u5948\u6e56, Annan DA\uff08\u5206\u62c5\uff09\u300c\u304c\u3093\u5e79\u7d30\u80de\u8840\u7ba1\u30cb\u30c3\u30c1\u3092\u6a19\u7684\u3068\u3057\u305f\u53e3\u8154\u304c\u3093\u6cbb\u7642\u3078\u306e\u5fdc\u7528\u300d<\/li>\n<li>\u4e2d\u5916\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u3000\u7814\u7a76\u6d3b\u52d5\u652f\u63f4\u30002021\u5e74\u5ea6\uff0c\u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff0930\u4e07\u5186\u300c\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u7642\u6cd5\u306b\u3088\u308b\u764c\u7dda\u7dad\u5316\u3078\u306e\u6291\u5236\u52b9\u679c\u6a5f\u5e8f\u306e\u691c\u8a3c\u300d<\/li>\n<li>\u7b2c14\u56de\u8cc7\u751f\u5802\u5973\u6027\u7814\u7a76\u8005\u30b5\u30a4\u30a8\u30f3\u30b9\u30b0\u30e9\u30f3\u30c8 2021\u5e74\u5ea6 \u9593\u77f3\u5948\u6e56\uff08\u4ee3\u8868\uff09100\u4e07\u5186 \u300c\u816b\u760d\u8840\u7ba1\u5236\u5fa1\u306b\u3088\u308b\u65b0\u3057\u3044\u304c\u3093\u306e\u8a3a\u65ad\u30fb\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u300d<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6><span style=\"color: #3366ff;\">2022\u5e74\u3000\u79d1\u7814\u8cbb\uff1a1,730\u4e07\u5186\u3000\u8ca1\u56e3\uff1a230\u4e07\u5186<\/span><\/h6>\n<ol>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u6311\u6226\u7684\u7814\u7a76\uff08\u840c\u82bd\uff092022\u3000\u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff09250\u4e07\u5186\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a22K19610\uff09\u300c\u304c\u3093\u3068\u611f\u67d3\u75c7\u306b\u5171\u901a\u3057\u305f\u8840\u6813\u5f62\u6210\u6a5f\u5e8f\u306e\u89e3\u660e\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08A\uff092022\u3000\u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff09940\u4e07\u5186\u3000\u9593\u77f3\u5948\u6e56, \u677e\u7530\u3000\u5f69\uff08\u5206\u62c5\uff09\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a21H04840\uff09\u300c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u56e0\u5b50\u6a19\u7684\u306b\u3088\u308b\u304c\u3093\u514d\u75ab\u306e\u6d3b\u6027\u5316\u3068\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u958b\u767a\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08B\uff092022\u3000\u6a0b\u7530\u6cf0\u6d69\uff08\u4ee3\u8868\uff09100\u4e07\u5186 \u6a0b\u7530\u4eac\u5b50\uff0c\u9593\u77f3\u5948\u6e56\uff08\u5206\u62c5\uff09\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a21H03019\uff09\u300c\u816b\u760d\u7279\u7570\u7684\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264\u3068\u30c9\u30e9\u30c3\u30b0\u30ea\u30dd\u30b8\u30b7\u30e7\u30cb\u30f3\u30b0\u306b\u3088\u308b\u65b0\u898f\u80ba\u764c\u6cbb\u7642\u306e\u958b\u767a\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08C\uff092022\u3000\u677e\u7530\u3000\u5f69\uff08\u4ee3\u8868\uff09130\u4e07\u5186\u3000\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a20K09900\uff09\u300c\u816b\u760d\u8840\u7ba1\u7531\u6765\u56e0\u5b50\u3092\u6a19\u7684\u3068\u3057\u305f\u816b\u760d\u6eb6\u89e3\u30a6\u30a4\u30eb\u30b9\u306e\u958b\u767a\u300d<\/li>\n<li>\u4e2d\u5916\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u3000\u7814\u7a76\u6d3b\u52d5\u652f\u63f4\u30002022\u5e74\u5ea6\uff0c\u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff0930\u4e07\u5186\u300c\u816b\u760d\u95a2\u9023\u597d\u4e2d\u7403\u306b\u5bfe\u3059\u308b\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u5f71\u97ff\u300d<\/li>\n<li>2022\u5e74\u5ea6\u65ed\u785d\u5b50\u8ca1\u56e3\u7814\u7a76\u52a9\u6210\u91d1\u3000\u9593\u77f3\u5948\u6e56\uff08\u4ee3\u8868\uff09200\u4e07\u5186\u300c\u8840\u7ba1\u751f\u7269\u5b66\u3068\u30de\u30a4\u30af\u30ed\u6d41\u4f53\u529b\u5b66\u306e\u878d\u5408\u306b\u3088\u308b\u65b0\u898f\u8ee2\u79fb\u8a3a\u65ad\u6cd5\u306e\u958b\u767a\u300d<\/li>\n<li>\u65e5\u672c\u5b66\u8853\u632f\u8208\u4f1a\u7279\u5225\u7814\u7a76\u54e1\u5968\u52b1\u8cbb\uff08DC2\uff092022 \u7a4d\u7530\u5353\u4e5f\u3000100\u4e07\u5186\u300c\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306b\u6ce8\u76ee\u3057\u305f\u300c\u304c\u3093\u300d\u3068\u300c\u5faa\u74b0\u5668\u75be\u60a3\u300d\u306e\u5171\u901a\u5206\u5b50\u75c5\u614b\u57fa\u76e4\u306e\u63a2\u7d22\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76(C) 2022\u3000\u9593\u77f3\u5948\u6e56\uff08\u4ee3\u8868\uff0980\u4e07\u5186\u300c\u304c\u3093\u3068\u816b\u760d\u8840\u7ba1\u306e\u76f8\u4e92\u4f5c\u7528\u306b\u3088\u308b\u65b0\u305f\u306a\u8ee2\u79fb\u4fc3\u9032\u6a5f\u69cb\u306e\u89e3\u660e\u3068\u305d\u306e\u5236\u5fa1\u300d\u6a0b\u7530\u4eac\u5b50, \u677e\u7530\u3000\u5f69\uff08\u5206\u62c5\u8005\uff09\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a21K10107\uff09<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76(C) 2022\u3000\u6885\u5c71\u60a0\u4f0a\uff08\u4ee3\u8868\uff09100\u4e07\u5186\u300c\u816b\u760d\u8840\u7ba1\u30c8\u30e9\u30f3\u30b9\u30dd\u30fc\u30bf\u30fc\u3092\u6a19\u7684\u3068\u3057\u305f\u85ac\u5264\u8010\u6027\u53e3\u8154\u304c\u3093\u306e\u5236\u5fa1\u300d\u6a0b\u7530\u4eac\u5b50, \u9593\u77f3\u5948\u6e56, \u677e\u7530\u3000\u5f69\uff08\u5206\u62c5\u8005\uff09\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a21K10036\uff09<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76(C) 2022\u3000\u4f50\u85e4\u5343\u6674\uff08\u4ee3\u8868\uff0930\u4e07\u5186\uff0c\u9593\u77f3\u5948\u6e56, Annan DA\uff08\u5206\u62c5\uff09\u300c\u304c\u3093\u5e79\u7d30\u80de\u8840\u7ba1\u30cb\u30c3\u30c1\u3092\u6a19\u7684\u3068\u3057\u305f\u53e3\u8154\u304c\u3093\u6cbb\u7642\u3078\u306e\u5fdc\u7528\u300d<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6><span style=\"color: #3366ff;\">2023\u5e74\u3000\u79d1\u7814\u8cbb\uff1a1,310\u4e07\u5186\u3000\u8ca1\u56e3\uff1a100\u4e07\u5186<\/span><\/h6>\n<ol>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08A\uff092023\u3000\u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff09850\u4e07\u5186\u3000\u9593\u77f3\u5948\u6e56, \u677e\u7530\u3000\u5f69\uff08\u5206\u62c5\uff09\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a21H04840\uff09\u300c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u56e0\u5b50\u6a19\u7684\u306b\u3088\u308b\u304c\u3093\u514d\u75ab\u306e\u6d3b\u6027\u5316\u3068\u65b0\u305f\u306a\u6cbb\u7642\u6cd5\u958b\u767a\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76\uff08B\uff092023\u3000\u6a0b\u7530\u6cf0\u6d69\uff08\u4ee3\u8868\uff09100\u4e07\u5186 \u6a0b\u7530\u4eac\u5b50\uff0c\u9593\u77f3\u5948\u6e56\uff08\u5206\u62c5\uff09\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a21H03019\uff09\u300c\u816b\u760d\u7279\u7570\u7684\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u5264\u3068\u30c9\u30e9\u30c3\u30b0\u30ea\u30dd\u30b8\u30b7\u30e7\u30cb\u30f3\u30b0\u306b\u3088\u308b\u65b0\u898f\u80ba\u764c\u6cbb\u7642\u306e\u958b\u767a\u300d<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u57fa\u76e4\u7814\u7a76(C) 2023\u3000\u9593\u77f3\u5948\u6e56\uff08\u4ee3\u8868\uff09110\u4e07\u5186\u300c\u304c\u3093\u3068\u816b\u760d\u8840\u7ba1\u306e\u76f8\u4e92\u4f5c\u7528\u306b\u3088\u308b\u65b0\u305f\u306a\u8ee2\u79fb\u4fc3\u9032\u6a5f\u69cb\u306e\u89e3\u660e\u3068\u305d\u306e\u5236\u5fa1\u300d\u6a0b\u7530\u4eac\u5b50, \u677e\u7530\u3000\u5f69\uff08\u5206\u62c5\u8005\uff09\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a21K10107\uff09<\/li>\n<li>\u6587\u79d1\u7701\u79d1\u7814\u6311\u6226\u7684\u7814\u7a76\uff08\u840c\u82bd\uff092023\u3000\u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff09250\u4e07\u5186\uff08\u7814\u7a76\u8ab2\u984c\u756a\u53f7\uff1a22K19610\uff09\u300c\u304c\u3093\u3068\u611f\u67d3\u75c7\u306b\u5171\u901a\u3057\u305f\u8840\u6813\u5f62\u6210\u6a5f\u5e8f\u306e\u89e3\u660e\u300d<\/li>\n<li>\u4e2d\u5916\u88fd\u85ac\u682a\u5f0f\u4f1a\u793e\u3000\u7814\u7a76\u6d3b\u52d5\u652f\u63f4\u30002023\u5e74\u5ea6\uff0c\u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff0930\u4e07\u5186\u300c\u816b\u760d\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u56e0\u5b50\u3068\u8840\u6813\u5f62\u6210\u30e1\u30ab\u30cb\u30ba\u30e0\u300d<\/li>\n<li>\u4f0a\u85e4\u533b\u85ac\u5b66\u8853\u4ea4\u6d41\u8ca1\u56e3\u3000\u7b2c29\u56de\uff082023\u5e74\u5ea6\uff09\u5b66\u4f1a\u7b49\u52a9\u6210\u3000\u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff09\u300045\u4e07\u5186<\/li>\n<li>\u4f0a\u85e4\u533b\u85ac\u5b66\u8853\u4ea4\u6d41\u8ca1\u56e3\u3000\u7b2c29\u56de\uff082023\u5e74\u5ea6\uff09\u6d77\u5916\u5b66\u4f1a\u7b49\u51fa\u5e2d\u7814\u7a76\u4ea4\u6d41\u52a9\u6210\u3000\u4f59\u3000\u9e97\uff08\u4ee3\u8868\uff0925\u4e07\u5186\u300c\u53e3\u8154\u7d30\u83cc\u306b\u3088\u308b\u304c\u3093\u306e\u8ee2\u79fb\uff5d<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<h5>\u00a0<\/h5>\n<h5>II\u3000AMED, JST, CREST\u4ed6<\/h5>\n<p><span style=\"color: #ff0000;\">5\u5e74\u9593\u5408\u8a08\u3000\u7dcf\u984d\uff1a11,530\u4e07\u5186<\/span><\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6><span style=\"color: #3366ff;\">2019\u5e74\u30002,300\u4e07\u5186<\/span><\/h6>\n<ol>\n<li>\u65e5\u672c\u533b\u7642\u7814\u7a76\u958b\u767a\u6a5f\u69cb (AMED) 2019-2020\u5e74\u5ea6\u3000\u9769\u65b0\u7684\u304c\u3093\u533b\u7642\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d\uff0c\u3000\u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff09 2019\u5e74\u5ea6\uff1a2,300\u4e07\u5186 \u300c\u816b\u760d\u8840\u7ba1\u30fb\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u306e\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u306e\u89e3\u660e\u3068\u65b0\u898f\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u7642\u6cd5\u306e\u958b\u767a\u300d<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6><span style=\"color: #3366ff;\">2020\u5e74\u30002,300\u4e07\u5186<\/span><\/h6>\n<ol>\n<li>\u65e5\u672c\u533b\u7642\u7814\u7a76\u958b\u767a\u6a5f\u69cb (AMED) 2019-2020\u5e74\u5ea6\u3000\u9769\u65b0\u7684\u304c\u3093\u533b\u7642\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d\uff0c\u3000\u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff09 2020\u5e74\u5ea6\uff1a2,300\u4e07\u5186 \u300c\u816b\u760d\u8840\u7ba1\u30fb\u304c\u3093\u5fae\u5c0f\u74b0\u5883\u306e\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u306e\u89e3\u660e\u3068\u65b0\u898f\u8840\u7ba1\u65b0\u751f\u963b\u5bb3\u7642\u6cd5\u306e\u958b\u767a\u300d<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6><span style=\"color: #3366ff;\">2021\u5e74\u30003,100\u4e07\u5186<\/span><\/h6>\n<ol>\n<li>\u65e5\u672c\u533b\u7642\u7814\u7a76\u958b\u767a\u6a5f\u69cb (AMED) 2021\u5e74\u5ea6\u3000\u65b0\u8208\u30fb\u518d\u8208\u611f\u67d3\u75c7\u306b\u5bfe\u3059\u308b\u9769\u65b0\u7684\u533b\u85ac\u54c1\u7b49\u958b\u767a\u63a8\u9032\u7814\u7a76\u4e8b\u696d, \u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff093,100\u4e07\u5186\u300cCOVID-19\u91cd\u75c7\u5316\u306b\u304a\u3051\u308b\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u611f\u67d3\u75c5\u614b\u89e3\u660e\u3068\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u300d\u3000<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6><span style=\"color: #3366ff;\">2022\u5e74\u30001,930\u4e07\u5186<\/span><\/h6>\n<ol>\n<li>\u6a4b\u6e21\u3057\u7814\u7a76\u30d7\u30ed\u30b0\u30e9\u30e02022\u5e74\u5ea6\u7814\u7a76\u958b\u767a\u30b7\u30fc\u30baA\u300c\u8840\u7ba1\u306e\u5236\u5fa1\u306b\u3088\u308b\u91cd\u75c7\u5316COVID-19\u6cbb\u7642\u85ac\u306e\u958b\u767a\u300d \u6a0b\u7530\u4eac\u5b50\uff08\u4ee3\u8868\uff09200\u4e07\u5186\u3000\u9593\u77f3\u5948\u6e56\uff08\u5206\u62c5\u8005\uff09<\/li>\n<li>\u65e5\u672c\u533b\u7642\u7814\u7a76\u958b\u767a\u6a5f\u69cb (AMED)2022-2024\uff08\u65b0\u8208\u30fb\u518d\u8208\u611f\u67d3\u75c7\u7814\u7a76\u57fa\u76e4\u5275\u751f\u4e8b\u696d\uff08\u591a\u5206\u91ce\u878d\u5408\u7814\u7a76\u9818\u57df\uff09\uff09\u9593\u77f3\u5948\u6e56\uff08\u4ee3\u8868\uff09\u30002022\u5e74\u5ea6\uff1a1,430\u4e07\u5186\u300c\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u75c5\u614b\u89e3\u660e\u306b\u3088\u308b\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a3\u30eb\u30b9\u611f\u67d3\u75c7\u91cd\u75c7\u5316\u306e\u5236\u5fa1\u300d<\/li>\n<li>\u65e5\u672c\u533b\u7642\u7814\u7a76\u958b\u767a\u6a5f\u69cb (AMED) 2022-2023\uff08\u6b21\u4e16\u4ee3\u304c\u3093\u533b\u7642\u52a0\u901f\u5316\u7814\u7a76\u4e8b\u696d\uff09\u9593\u77f3\u5948\u6e56\uff08\u4ee3\u8868\uff092022\u5e74\u5ea6\uff1a500\u4e07\u5186\u300cCell cluster\u5f62\u6210\u306b\u3088\u308b\u304c\u3093\u60aa\u6027\u5316\u4fc3\u9032\u6a5f\u69cb\u306e\u89e3\u660e\u3068\u65b0\u898f\u8a3a\u65ad\u30fb\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u300d<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<h6><span style=\"color: #3366ff;\">2023\u5e74\u30001,700\u4e07\u5186<\/span><\/h6>\n<ol>\n<li>\u65e5\u672c\u533b\u7642\u7814\u7a76\u958b\u767a\u6a5f\u69cb (AMED)2022-2024\uff08\u65b0\u8208\u30fb\u518d\u8208\u611f\u67d3\u75c7\u7814\u7a76\u57fa\u76e4\u5275\u751f\u4e8b\u696d\uff08\u591a\u5206\u91ce\u878d\u5408\u7814\u7a76\u9818\u57df\uff09\uff09\u9593\u77f3\u5948\u6e56\uff08\u4ee3\u8868\uff09\u30002023\u5e74\u5ea6\uff1a1,200\u4e07\u5186\u300c\u8840\u7ba1\u5185\u76ae\u7d30\u80de\u306e\u75c5\u614b\u89e3\u660e\u306b\u3088\u308b\u65b0\u578b\u30b3\u30ed\u30ca\u30a6\u30a3\u30eb\u30b9\u611f\u67d3\u75c7\u91cd\u75c7\u5316\u306e\u5236\u5fa1\u300d<\/li>\n<li>\u65e5\u672c\u533b\u7642\u7814\u7a76\u958b\u767a\u6a5f\u69cb (AMED) 2022-2023\uff08\u6b21\u4e16\u4ee3\u304c\u3093\u533b\u7642\u52a0\u901f\u5316\u7814\u7a76\u4e8b\u696d\uff09\u9593\u77f3\u5948\u6e56\uff08\u4ee3\u8868\uff092023\u5e74\u5ea6\uff1a500\u4e07\u5186\u300cCell cluster\u5f62\u6210\u306b\u3088\u308b\u304c\u3093\u60aa\u6027\u5316\u4fc3\u9032\u6a5f\u69cb\u306e\u89e3\u660e\u3068\u65b0\u898f\u8a3a\u65ad\u30fb\u6cbb\u7642\u6cd5\u306e\u958b\u767a\u300d<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"\u8ad6\u6587 \u5927\u578b\u5171\u540c\u7814\u7a76\u8cbb \u7523\u696d\u5275\u51fa\u90e8\u9580\u306e\u5275\u8a2d \u7279\u8a31 \u533b\u5e2b\u30fb\u4f01\u696d\u3068\u306e\u5171\u540c\u7814\u7a76 \u7af6\u4e89\u7684\u8cc7\u91d1 \uff15\u5e74\u9593\u5168\u4f53 \u539f\u8457\u8ad6\u6587\uff1a22\u5831\uff084+3+6+6+3\uff1d22\uff09Top10%\u88ab\u5f15\u7528\u8ad6\u6587\u306e\u5272\u540845.5\uff05 \u7dcf\u8aac\uff1a7\u5831\uff081+1+1+1+3\uff1d7\uff09To&#8230; <a class=\"view-article\" href=\"https:\/\/www.pharm.hokudai.ac.jp\/nano\/dentistry\/result\">View Article<\/a>","protected":false},"author":2,"featured_media":0,"parent":16,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-dentistry_result.php","meta":{"footnotes":""},"class_list":["post-729","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/pages\/729","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/comments?post=729"}],"version-history":[{"count":9,"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/pages\/729\/revisions"}],"predecessor-version":[{"id":748,"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/pages\/729\/revisions\/748"}],"up":[{"embeddable":true,"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/pages\/16"}],"wp:attachment":[{"href":"https:\/\/www.pharm.hokudai.ac.jp\/nano\/wp-json\/wp\/v2\/media?parent=729"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}